2020
DOI: 10.1007/s11033-020-05261-5
|View full text |Cite
|
Sign up to set email alerts
|

Implication and role of neutrophil gelatinase-associated lipocalin in cancer: lipocalin-2 as a potential novel emerging comprehensive therapeutic target for a variety of cancer types

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
20
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 31 publications
(22 citation statements)
references
References 141 publications
0
20
0
Order By: Relevance
“…Finally, the CLUSTER S/SEV OSCC_LNM was specifically associated to GO groups related to activities against pathogen agents, such as "metal sequestration by antimicrobial proteins" (associated to LCN2, LTF, S100A9-see Table 6 for the FC in S/SEV OSCC_LNM); "growth of symbiont in host" (associated to ELANE, MPO, PGLYRP1-see Table 6 for the FC in S/SEV OSCC_LNM); and "antimicrobial peptides" (associated to ELANE, GAPDH, LCN2, LTF, MPO, PGLYRP1, PI3, PRTN3, RNASE3, S100A12, S100A9-see Table 6 for the FC in S/SEV OSCC_LNM). Proteins of these groups, such as lactoferrin (LFT,), lipocalin-2 (LCN2), S100A9 (forming with S100A8 the heterodimeric complex calprotectin), neutrophil elastase (ELANE), peptidoglycan recognition protein 1 (PGLYRP1), and myeloperoxidase (MPO), are widely described for their antibacterial activity or for their role as inflammatory markers [44][45][46][47][48]. The enrichment of these proteins in the S/SEVs from patients with OSCC_LNM could be indicative of dysbiotic signatures occurring during tumor progression.…”
Section: Discussionmentioning
confidence: 99%
“…Finally, the CLUSTER S/SEV OSCC_LNM was specifically associated to GO groups related to activities against pathogen agents, such as "metal sequestration by antimicrobial proteins" (associated to LCN2, LTF, S100A9-see Table 6 for the FC in S/SEV OSCC_LNM); "growth of symbiont in host" (associated to ELANE, MPO, PGLYRP1-see Table 6 for the FC in S/SEV OSCC_LNM); and "antimicrobial peptides" (associated to ELANE, GAPDH, LCN2, LTF, MPO, PGLYRP1, PI3, PRTN3, RNASE3, S100A12, S100A9-see Table 6 for the FC in S/SEV OSCC_LNM). Proteins of these groups, such as lactoferrin (LFT,), lipocalin-2 (LCN2), S100A9 (forming with S100A8 the heterodimeric complex calprotectin), neutrophil elastase (ELANE), peptidoglycan recognition protein 1 (PGLYRP1), and myeloperoxidase (MPO), are widely described for their antibacterial activity or for their role as inflammatory markers [44][45][46][47][48]. The enrichment of these proteins in the S/SEVs from patients with OSCC_LNM could be indicative of dysbiotic signatures occurring during tumor progression.…”
Section: Discussionmentioning
confidence: 99%
“…LCN2 is known to play dual roles in mediating the progression of tumorigenesis. One role involves the promotion of tumorigenesis by increasing cell proliferation, the metastatic potential and independent predictor for severity of grades and stages of tumors [ 26 , 27 ]. In vitro and in vivo studies have shown that LCN2 promotes cell invasion and migration and distant metastasis in prostate cancer via the ERK signaling pathway, causing up-regulation of the SLUG transcription factor to induce the EMT [ 5 ].…”
Section: Discussionmentioning
confidence: 99%
“…Lcn-2/ NGAL, is a member of the lipocalin family, which shares a tight tertiary structure, and ligand binding and post-translational modifications in Lcn-2 leads to diverse Lcn-2 functions (87). Lcn-2 is considered a therapeutic target for AKI, CKD and numerous types of cancer such as breast, esophagus and liver cancer (87)(88)(89). Lcn-2 plays a pivotal role in various kidney diseases, such as sepsis and IR (90).…”
Section: Macrophage-derived Mediators In Akimentioning
confidence: 99%